| Title |
|
Pulmonary embolus in patients with COVID-19: an Australian perspective. |
|
|
| Publication Date |
|
| Author(s) |
|
| Subject |
|
| Type of document |
|
| OrcId |
|
| DOI |
|
| Abstract |
|
Pulmonary embolus (PE) is a known complication of coronavirus disease 2019 (COVID-19). The diagnosis of PE in our hospitalised patients with COVID-19 correlated with more severe disease and occurred despite the use of routine thromboprophylaxis. Higher D-dimers were seen on admission in patients who developed PE and rose at PE diagnosis, suggesting a role for D-dimer in risk stratification. |
|
|
| Link |
|
| Citation |
|
Internal Medicine Journal 2021; 51(8): 1324-1327 |
|
|
| Jornal Title |
|
Internal Medicine Journal |
|
|
